封面
市場調查報告書
商品編碼
2176465

微膠囊益生菌食品配料市場預測至2034年-全球益生菌微生物、包埋技術、包埋材料、配料形式、食品應用及區域分析

Microencapsulated Probiotic Food Ingredients Market Forecasts to 2034 - Global Analysis By Probiotic Microorganism, By Encapsulation Technology, By Encapsulation Material, By Ingredient Form, By Food Application and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 300+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,預計到 2026 年,全球微膠囊益生菌食品配料市場規模將達到 13.2 億美元,在預測期內以 11.6% 的複合年成長率成長,到 2034 年將達到 31.76 億美元。

微膠囊化益生菌食品配料包括專為滿足特定功能和商業性性能要求而設計的專用產品和解決方案。這些產品在材料成分、製造技術、應用和客戶需求方面存在差異。製造商選擇原料和加工條件,以確保產品品質穩定可靠,並具備良好的操作性能。產品規格會影響其與下游生產和分銷系統的兼容性。品質保證、法規遵循和供應可靠性是整個價值鏈中的關鍵考慮因素。供應商透過配方專業知識、工藝一致性、技術支援以及與相關客戶的聯繫來競爭。

機能性食品對高穩定性益生菌成分的需求日益成長

市場對高性能微膠囊益生菌食品配料的需求日益成長,促使生產商拓展產品系列。買家對供應商的品質穩定性、規格說明和交貨可靠性提出了更高的要求。加工和配方技術的進步使得產品特性和最終用途性能的控制更加精準。根據客戶個性化需求客製化產品的能力有助於市場滲透。不斷擴展的分銷和技術支援網路提高了專業產品的可及性。這些因素共同提升了消費者的購買意願,並推動了整個產業的廣泛應用。

活細胞數量減少和微膠囊化過程高成本。

高昂的認證和加工成本會阻礙微膠囊益生菌食品配料的商業性應用。供應商必須權衡原料品質、生產效率和具競爭力的售價。不同批次原料的性能差異會使生產和客戶檢驗變得複雜。小規模生產商可能缺乏穩定生產所需的設備和技術人員。複雜的認證和產品文件要求會延長採購決策時間。這些限制可能會延緩產能擴張,並限制價格敏感型客戶的進入。

應用範圍包括保存期限長的食品和創新保護塗層。

產品創新為供應商創造了機會,使其能夠通過可衡量的性能指標,在微膠囊益生菌食品配料領域中脫穎而出。與客戶的合作開發有助於識別尚未滿足的規格要求,並提升產品在實際應用中的適用性。製造商可以透過針對性的配方和加工技術的改進,將業務拓展到相鄰的應用領域。數位化品質追蹤增強了可追溯性,並有助於建立客戶信任。區域供應夥伴關係可以縮短交貨週期,並提高對不斷變化的需求的應對力。專業化的產品等級有助於簽訂更高價值的契約,並建立更牢固、更長期的客戶關係。

嚴格的健康標籤法規和來自其他微生物組成分的競爭。

現有替代品的競爭對微膠囊益生菌食品配料的推廣應用構成威脅。原物料供應的變化會擾亂生產計畫和成本預估。意外的監管變化可能需要修改配方、進行額外測試或編制新的文件。大型競爭對手的激進定價策略會擠壓小規模企業的利潤空間。客戶集中度的提高會增加採購延遲和合約重新談判的風險。技術替代和產品性能的變化可能會削弱長期需求。

新冠疫情的影響

新冠疫情擾亂了價值鏈,導致特殊原料採購困難。運輸限制和工廠臨時停工造成生產和交貨延誤。在不確定的情況下,一些客戶推遲了認證項目和非必要的資本投資。生產商則透過供應商多元化和加強庫存管理系統來應對。隨著業務營運的調整,遠端技術協調和數位化採購的重要性日益凸顯。在復甦階段,具有韌性的採購系統和靈活的生產能力的價值也隨之顯現。

預計在預測期內,源自乳酸桿菌的培養物部分將佔據最大佔有率。

乳酸桿菌衍生培養物具有許多優勢,例如採購慣例成熟,且與相關應用領域相容性廣泛。客戶對其在現有採購管道中的便利性和熟悉度表示讚賞。供應商已圍繞該產品建立了加工技術和分銷網路。其規格可整合到傳統的生產和品管流程中。持續的產品改進有助於維持品質穩定,並有助於維繫現有用戶。這些優勢支撐了市場需求,並增強了其對整體市場成長的貢獻。

預計在預測期內,「嬰幼兒及特殊營養」細分市場將呈現最高的複合年成長率。

嬰幼兒及特殊營養品領域預計將受益於新興的應用需求和產品差異化。研發活動正在拓寬潛在客戶可選擇的性能特徵範圍。早期採用者可能會優先考慮改進的流程整合和更專業的功能。隨著商業性銷售量的成長,供應商的投資可能會降低採用門檻。技術合作和改進的分銷系統可能會加速更廣泛客戶的評估。這些趨勢可能會推動產品普及並促進市場成長。

市佔率最大的地區:

北美地區擁有成熟的製造網路和完善的採購慣例,為其發展提供了有利條件。該地區的買家重視技術規格、合規性和供應可靠性。供應商的研發能力支援配方改進和應用測試。完善的分銷管道提高了產品在客戶群中的可及性。品質認證和可追溯性要求也為已建立的商業性關係提供了支持。這些條件為持續進入市場創造了有利環境。

複合年成長率最高的地區:

亞太地區的發展動力源自於不斷擴大的製造業產能和日益多元化的終端用戶需求。工業投資正在改善該地區獲取先進加工和品管設備的管道。區域供應商正在加強產品開發和分銷能力。客戶意識的提升使他們更加重視差異化材料和解決方案。供應鏈本地化正在縮短前置作業時間並提高價格競爭力。這些趨勢為多個區域經濟體的持續應用創造了空間。

主要公司:

微膠囊益生菌食品配料市場的主要參與者包括 Kerry Group plc、Novonesis、IFF、Lallemand Inc.、Probi AB、BioGaia AB、Chr. Hansen Holding A/S、Lesaffre、Sacco System、森永乳業株式會社、Kaneka Corporation、Synbio Tech Inc.、AB-BIOTICS Technologies.、AB-BIS Technologies Ltd., Anacroka Corporation、Synbio Tech.、AB-BIOTICS)、Microdel Corporation、Synbio Tech.、AB-BIOTICS)、Microka Corporation、Synbio Tech.、AB-BIOTICS)、Microka Corporation、Synbio Tech.、AB-BIOTICS)、Microka Corporation、Synbio Tech.、AB-BIMICS 組合、Microka Corporation。

本報告內容:

對區域和國家特定細分市場的市場佔有率進行評估

給新參與企業的策略建議

涵蓋 2023 年、2024 年、2025 年、2026 年、2027 年、2028 年、2030 年、2032 年和 2034 年的市場數據。

市場趨勢(促進因素、阻礙因素、威脅、挑戰、投資機會和建議)

基於市場預測的關鍵業務部門策略建議

競爭格局圖視覺化關鍵通用趨勢

公司簡介,包括詳細策略、財務狀況和近期發展

反映最新技術進步的供應鏈趨勢

免費客製化服務:

所有購買此報告的客戶均可享受以下免費自訂選項之一:

  • 公司簡介
    • 對其他市場參與者(最多 3 家公司)進行全面分析
    • 對主要公司進行SWOT分析(最多3家公司)
  • 區域細分
    • 根據客戶要求,我們可以提供主要國家的市場估算和預測,以及複合年成長率(註:需經可行性確認)。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章:研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章:競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章:全球微膠囊益生菌食品配料市場:依益生菌微生物分類

  • 源自乳桿菌科的培養物
  • 源自雙歧桿菌的培養物
  • 芽孢桿菌屬的孢子形成真菌
  • 酵母菌衍生培養物
  • 多菌株益生菌混合物
  • 其他益生菌微生物

第6章 全球微膠囊益生菌食品配料市場:依膠囊化技術分類

  • 噴霧乾燥
  • 採用保護性基質進行凍乾
  • 擠出封裝
  • 乳化法包封
  • 流體化床塗層
  • 其他封裝技術

第7章 全球微膠囊益生菌食品配料市場:依膠囊材料分類

  • 多醣體基質
  • 蛋白質基質
  • 脂質基質
  • 複合封裝基質
  • 其他封裝材料

第8章:全球微膠囊益生菌食品配料市場:依配料形式分類

  • 乾燥粉末和顆粒
  • 微珠和膠囊
  • 液體分散體
  • 其他原料形式

第9章:全球微膠囊益生菌食品配料市場:依食品應用分類

  • 乳製品
  • 植物來源乳製品替代品
  • 烘焙產品
  • 糖果甜點和零食
  • 機能飲料
  • 嬰幼兒營養補充品
  • 其他食品用途

第10章 全球微膠囊益生菌食品配料市場:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區(RoW)
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章:公司簡介

  • Kerry Group plc
  • Novonesis
  • IFF
  • Lallemand Inc.
  • Probi AB
  • BioGaia AB
  • Chr. Hansen Holding A/S
  • Lesaffre
  • Sacco System
  • Morinaga Milk Industry Co., Ltd.
  • Kaneka Corporation
  • Synbio Tech Inc.
  • AB-BIOTICS SA
  • Micro-Sphere SA
  • AnaBio Technologies Ltd.
Product Code: SMRC41133

According to Stratistics MRC, the Global Microencapsulated Probiotic Food Ingredients Market is accounted for $1,320 million in 2026 and is expected to reach $3,176 million by 2034 growing at a CAGR of 11.6% during the forecast period. Microencapsulated Probiotic Food Ingredients encompasses specialized products and solutions designed for applications requiring defined functional and commercial performance. These offerings are differentiated by material composition, production techniques, intended use and customer requirements. Manufacturers select inputs and processing conditions to deliver repeatable quality and suitable handling characteristics. Product specifications influence compatibility with downstream production and distribution systems. Quality assurance, regulatory conformity and supply reliability are important considerations throughout the value chain. Suppliers compete through formulation expertise, process consistency, technical support and access to relevant customers.

Market Dynamics:

Driver:

Growing demand for stable probiotic ingredients in functional foods

Growing demand for performance-oriented microencapsulated probiotic food ingredients is encouraging manufacturers to broaden their product portfolios. Buyers increasingly seek consistent quality, documented specifications and dependable delivery from suppliers. Advances in processing and formulation enable better control of product characteristics and end-use performance. Commercial adoption is supported by the ability to tailor offerings for distinct customer requirements. Expansion of distribution and technical support networks improves access to specialized products. Together, these factors strengthen purchasing interest and support broader industry adoption.

Restraint:

Viability losses and high costs of microencapsulation processes

High qualification and processing costs can restrict the commercial adoption of microencapsulated probiotic food ingredients. Suppliers must balance material quality with production efficiency and competitive selling prices. Performance variability between input batches can complicate manufacturing and customer validation. Smaller producers may lack the equipment and technical personnel needed for consistent output. Complex certification or product documentation requirements can lengthen procurement decisions. These constraints may slow capacity additions and limit participation by price-sensitive customers.

Opportunity:

Expansion into shelf-stable foods and innovative protective coatings

Product innovation creates opportunities for suppliers to differentiate microencapsulated probiotic food ingredients by measurable performance. Joint development with customers can identify unmet specifications and improve application fit. Manufacturers can expand into adjacent use cases through targeted formulations and processing improvements. Digital quality tracking offers opportunities to strengthen traceability and customer confidence. Regional supply partnerships may reduce delivery times and improve responsiveness to demand changes. Specialized product grades can support higher-value contracts and stronger long-term customer relationships.

Threat:

Stringent health-claim rules and competition from alternative microbiome ingredients

Competition from established alternatives poses a threat to the adoption of microencapsulated probiotic food ingredients. Changes in raw material availability can disrupt production planning and cost assumptions. Unexpected regulatory revisions may require reformulation, additional testing or new documentation. Aggressive pricing by large competitors can compress margins for smaller participants. Customer concentration increases exposure to procurement delays and contract renegotiations. Technological substitution and inconsistent product performance could weaken long-term demand.

COVID-19 Impact

The COVID-19 pandemic disrupted supply chains and complicated the procurement of specialized inputs. Transport restrictions and temporary plant shutdowns created delays in production and delivery. Some customers deferred qualification projects and nonessential capital expenditure during periods of uncertainty. Producers responded by diversifying suppliers and strengthening inventory management practices. Remote technical coordination and digital purchasing gained importance as business operations adapted. The recovery highlighted the value of resilient sourcing and flexible manufacturing capacity.

Lactobacillaceae-Based Cultures segment is expected to hold the largest share during the forecast period

The Lactobacillaceae-Based Cultures segment benefits from established purchasing practices and broad compatibility with relevant applications. Customers value its availability and familiarity within existing procurement channels. Suppliers have developed processing expertise and distribution relationships around this offering. Its specifications can be integrated into conventional manufacturing and quality-control routines. Ongoing product refinement supports consistency and helps retain existing users. These advantages sustain demand and reinforce its contribution to overall market growth.

Infant and Specialized Nutrition segment is expected to have the highest CAGR during the forecast period

The Infant and Specialized Nutrition segment is positioned to benefit from emerging application requirements and product differentiation. Development activity is expanding the range of performance attributes available to prospective customers. Early adopters may value improved process integration or more specialized functionality. Supplier investment can reduce implementation barriers as commercial volumes increase. Technical collaborations and improved distribution may accelerate wider customer evaluation. These developments could encourage adoption and enhance market growth.

Region with largest share:

North America benefits from established manufacturing networks and sophisticated procurement practices. The region hosts buyers that prioritize technical specifications, compliance and supply reliability. Supplier research capabilities support formulation improvements and application testing. Well-developed distribution channels improve product accessibility across customer groups. Quality certification and traceability requirements also favor established commercial relationships. These conditions provide a supportive environment for continued market participation.

Region with highest CAGR:

Asia Pacific is supported by expanding manufacturing capacity and increasingly diverse end-use demand. Industrial investment is improving access to modern processing and quality-control equipment. Regional suppliers are strengthening product development and distribution capabilities. Growing customer awareness encourages evaluation of differentiated materials and solutions. Localization of supply chains can reduce lead times and support competitive pricing. These trends provide scope for sustained adoption across multiple regional economies.

Key Players:

Some of the key players in the Microencapsulated Probiotic Food Ingredients Market include Kerry Group plc, Novonesis, IFF, Lallemand Inc., Probi AB, BioGaia AB, Chr. Hansen Holding A/S, Lesaffre, Sacco System, Morinaga Milk Industry Co., Ltd., Kaneka Corporation, Synbio Tech Inc., AB-BIOTICS SA, Micro-Sphere SA, and AnaBio Technologies Ltd.

Key Developments:

In October 2026, Lallemand Health Solutions announced Probium, a ready-to-market portfolio of probiotic and multi-ingredient formulations. The launch supports faster commercialization of targeted microbiome products.

In May 2026, Probi introduced Rham271h, its first postbiotic solution, at Vitafoods Europe. The expansion into shelf-stable postbiotics addresses formulation challenges associated with live microbial ingredients.

In July 2025, DSM-Firmenich publicized clinical research on a synbiotic preparation combined with microencapsulated sodium butyrate. The research supports development of encapsulated gut-health formulations with improved delivery flexibility.

Probiotic Microorganism Covered:

  • Lactobacillaceae-Based Cultures
  • Bifidobacterium-Based Cultures
  • Bacillus-Based Spore-Formers
  • Saccharomyces-Based Cultures
  • Multi-Strain Probiotic Blends
  • Other Probiotic Microorganisms

Encapsulation Technology Covered:

  • Spray Drying
  • Freeze Drying with Protective Matrices
  • Extrusion Encapsulation
  • Emulsion-Based Encapsulation
  • Fluidized-Bed Coating
  • Other Encapsulation Technologies

Encapsulation Material Covered:

  • Polysaccharide-Based Matrices
  • Protein-Based Matrices
  • Lipid-Based Matrices
  • Composite Encapsulation Matrices
  • Other Encapsulation Materials

Ingredient Form Covered:

  • Dry Powder and Granules
  • Microbeads and Capsules
  • Liquid Dispersions
  • Other Ingredient Forms

Food Application Covered:

  • Dairy Products
  • Plant-Based Dairy Alternatives
  • Bakery Products
  • Confectionery and Snacks
  • Functional Beverages
  • Infant and Specialized Nutrition
  • Other Food Applications

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments

Strategic recommendations for the new entrants

Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034

Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)

Strategic recommendations in key business segments based on the market estimations

Competitive landscaping mapping the key common trends

Company profiling with detailed strategies, financials, and recent developments

Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Microencapsulated Probiotic Food Ingredients Market, By Probiotic Microorganism

  • 5.1 Lactobacillaceae-Based Cultures
  • 5.2 Bifidobacterium-Based Cultures
  • 5.3 Bacillus-Based Spore-Formers
  • 5.4 Saccharomyces-Based Cultures
  • 5.5 Multi-Strain Probiotic Blends
  • 5.6 Other Probiotic Microorganisms

6 Global Microencapsulated Probiotic Food Ingredients Market, By Encapsulation Technology

  • 6.1 Spray Drying
  • 6.2 Freeze Drying with Protective Matrices
  • 6.3 Extrusion Encapsulation
  • 6.4 Emulsion-Based Encapsulation
  • 6.5 Fluidized-Bed Coating
  • 6.6 Other Encapsulation Technologies

7 Global Microencapsulated Probiotic Food Ingredients Market, By Encapsulation Material

  • 7.1 Polysaccharide-Based Matrices
  • 7.2 Protein-Based Matrices
  • 7.3 Lipid-Based Matrices
  • 7.4 Composite Encapsulation Matrices
  • 7.5 Other Encapsulation Materials

8 Global Microencapsulated Probiotic Food Ingredients Market, By Ingredient Form

  • 8.1 Dry Powder and Granules
  • 8.2 Microbeads and Capsules
  • 8.3 Liquid Dispersions
  • 8.4 Other Ingredient Forms

9 Global Microencapsulated Probiotic Food Ingredients Market, By Food Application

  • 9.1 Dairy Products
  • 9.2 Plant-Based Dairy Alternatives
  • 9.3 Bakery Products
  • 9.4 Confectionery and Snacks
  • 9.5 Functional Beverages
  • 9.6 Infant and Specialized Nutrition
  • 9.7 Other Food Applications

10 Global Microencapsulated Probiotic Food Ingredients Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Kerry Group plc
  • 13.2 Novonesis
  • 13.3 IFF
  • 13.4 Lallemand Inc.
  • 13.5 Probi AB
  • 13.6 BioGaia AB
  • 13.7 Chr. Hansen Holding A/S
  • 13.8 Lesaffre
  • 13.9 Sacco System
  • 13.10 Morinaga Milk Industry Co., Ltd.
  • 13.11 Kaneka Corporation
  • 13.12 Synbio Tech Inc.
  • 13.13 AB-BIOTICS SA
  • 13.14 Micro-Sphere SA
  • 13.15 AnaBio Technologies Ltd.

List of Tables

  • Table 1 Global Microencapsulated Probiotic Food Ingredients Market Region Outlook (2023-2034) ($MN)
  • Table 2 Global Microencapsulated Probiotic Food Ingredients Market Probiotic Microorganism Outlook (2023-2034) ($MN)
  • Table 3 Global Microencapsulated Probiotic Food Ingredients Market Lactobacillaceae-Based Cultures Outlook (2023-2034) ($MN)
  • Table 4 Global Microencapsulated Probiotic Food Ingredients Market Bifidobacterium-Based Cultures Outlook (2023-2034) ($MN)
  • Table 5 Global Microencapsulated Probiotic Food Ingredients Market Bacillus-Based Spore-Formers Outlook (2023-2034) ($MN)
  • Table 6 Global Microencapsulated Probiotic Food Ingredients Market Saccharomyces-Based Cultures Outlook (2023-2034) ($MN)
  • Table 7 Global Microencapsulated Probiotic Food Ingredients Market Multi-Strain Probiotic Blends Outlook (2023-2034) ($MN)
  • Table 8 Global Microencapsulated Probiotic Food Ingredients Market Other Probiotic Microorganisms Outlook (2023-2034) ($MN)
  • Table 9 Global Microencapsulated Probiotic Food Ingredients Market Encapsulation Technology Outlook (2023-2034) ($MN)
  • Table 10 Global Microencapsulated Probiotic Food Ingredients Market Spray Drying Outlook (2023-2034) ($MN)
  • Table 11 Global Microencapsulated Probiotic Food Ingredients Market Freeze Drying with Protective Matrices Outlook (2023-2034) ($MN)
  • Table 12 Global Microencapsulated Probiotic Food Ingredients Market Extrusion Encapsulation Outlook (2023-2034) ($MN)
  • Table 13 Global Microencapsulated Probiotic Food Ingredients Market Emulsion-Based Encapsulation Outlook (2023-2034) ($MN)
  • Table 14 Global Microencapsulated Probiotic Food Ingredients Market Fluidized-Bed Coating Outlook (2023-2034) ($MN)
  • Table 15 Global Microencapsulated Probiotic Food Ingredients Market Other Encapsulation Technologies Outlook (2023-2034) ($MN)
  • Table 16 Global Microencapsulated Probiotic Food Ingredients Market Encapsulation Material Outlook (2023-2034) ($MN)
  • Table 17 Global Microencapsulated Probiotic Food Ingredients Market Polysaccharide-Based Matrices Outlook (2023-2034) ($MN)
  • Table 18 Global Microencapsulated Probiotic Food Ingredients Market Protein-Based Matrices Outlook (2023-2034) ($MN)
  • Table 19 Global Microencapsulated Probiotic Food Ingredients Market Lipid-Based Matrices Outlook (2023-2034) ($MN)
  • Table 20 Global Microencapsulated Probiotic Food Ingredients Market Composite Encapsulation Matrices Outlook (2023-2034) ($MN)
  • Table 21 Global Microencapsulated Probiotic Food Ingredients Market Other Encapsulation Materials Outlook (2023-2034) ($MN)
  • Table 22 Global Microencapsulated Probiotic Food Ingredients Market Ingredient Form Outlook (2023-2034) ($MN)
  • Table 23 Global Microencapsulated Probiotic Food Ingredients Market Dry Powder and Granules Outlook (2023-2034) ($MN)
  • Table 24 Global Microencapsulated Probiotic Food Ingredients Market Microbeads and Capsules Outlook (2023-2034) ($MN)
  • Table 25 Global Microencapsulated Probiotic Food Ingredients Market Liquid Dispersions Outlook (2023-2034) ($MN)
  • Table 26 Global Microencapsulated Probiotic Food Ingredients Market Other Ingredient Forms Outlook (2023-2034) ($MN)
  • Table 27 Global Microencapsulated Probiotic Food Ingredients Market Food Application Outlook (2023-2034) ($MN)
  • Table 28 Global Microencapsulated Probiotic Food Ingredients Market Dairy Products Outlook (2023-2034) ($MN)
  • Table 29 Global Microencapsulated Probiotic Food Ingredients Market Plant-Based Dairy Alternatives Outlook (2023-2034) ($MN)
  • Table 30 Global Microencapsulated Probiotic Food Ingredients Market Bakery Products Outlook (2023-2034) ($MN)
  • Table 31 Global Microencapsulated Probiotic Food Ingredients Market Confectionery and Snacks Outlook (2023-2034) ($MN)
  • Table 32 Global Microencapsulated Probiotic Food Ingredients Market Functional Beverages Outlook (2023-2034) ($MN)
  • Table 33 Global Microencapsulated Probiotic Food Ingredients Market Infant and Specialized Nutrition Outlook (2023-2034) ($MN)
  • Table 34 Global Microencapsulated Probiotic Food Ingredients Market Other Food Applications Outlook (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.